Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ: ILMN )

104.13 +1.13 (+1.10%)
Streaming Delayed Price Updated: 10:14 AM EST, Feb 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
31 32 Next >
DNA Data Storage Alliance Welcomes 50th Member
From DNA Data Storage Alliance
Via Business Wire
Analyst Ratings For Illumina
Illumina (NASDAQ:ILMN) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Illumina's Q4 Profit Falls Despite Topline Growth Of 26%
Illumina Inc (NASDAQ: ILMN) reported  
Via Benzinga
3 Top S&P 500 Stock Market Gainers Today: Medicals Lead As This Sector Reverses Hard
Medical and gold stocks led the S&P 500. Transport stocks were big losers. 
Via Investor's Business Daily
April Fool
Today China pushed its iron ore price to an 8 month high to help pay for pricey oil and gas. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2022
Upgrades 
Via Benzinga
Join Illumina on World Tuberculosis Day to Raise Awareness and Keep the Fight Up to Eradicate TB
SOURCE: Illumina 
Via 3BL Media
Illumina Celebrates Shannon Whitmore: A Real Time Revolutionary and Scientific Computing Innovator
SOURCE: Illumina 
Via 3BL Media
Illumina Accelerator Invests in Seven Omics Startups Advancing Breakthrough Therapeutics, Diagnostics, DNA Storage, Mental Wellness, and Sustainable Foods Applications
SOURCE: Illumina 
Via 3BL Media
Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe
SOURCE: Illumina 
Via 3BL Media
Illumina Launches Multiple-Gene Diagnostic Test For Cancer Patients
Illumina Inc (NASDAQ: ILMN) has launched TruSight Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumor genes and biomarkers to reveal the... 
Via Benzinga
Illumina and Trivitron Partner to Accelerate Disease Detection and Diagnosis for Patients in India
SOURCE: Illumina 
Via 3BL Media
Illumina Named One of Fast Company's Most Innovative Companies for 2022
SOURCE: Illumina 
Via 3BL Media
Celebrating Women's History Month: Illumina Spotlights Scientist Geraldine Pittman Woods
SOURCE: Illumina 
Via 3BL Media
Illumina's Technology Supports Biodiversity and Conservation Initiatives
SOURCE: Illumina 
Via 3BL Media
Illumina Celebrates Rare Disease Day
SOURCE: Illumina 
Via 3BL Media
CNBC's Final Trades: iShares MSCI UK, Illumina, US Silica And This Company That Has An Attractive Buyout Deal
On CNBC’s “Halftime Report... 
Via Benzinga
“The World Expands”: Celebrating Rare Disease Day in Japan
SOURCE: Illumina 
Via 3BL Media
Bionano Stock Looks to Have a Monster Comeback in Its Future
Bionano's Saphyr appears to be able to help doctors treat leukemia, and the adoption of its device is growing rapidly. 
Via InvestorPlace
African Coronavirus Surveillance Network Provides Early Warning for World
SOURCE: Illumina 
Via 3BL Media
Exposures COVID-19
Give peace a chance
Israeli fabless semiconductor maker Tower was bought by Intel for $5.4 bn today. 
Via Talk Markets
From Patents to Patients: Meet the Women Making a Difference at Illumina
SOURCE: Illumina 
Via 3BL Media
Topics Intellectual Property
Exposures Intellectual Property
Illumina to Support Neuro Genomics Project at McGill University
SOURCE: Illumina 
Via 3BL Media
Barron's Latest Picks And Pans: Zillow, Coca Cola, Illumina, Spotify And More
This weekend's Barron's cover story says there will be a dramatic increase in betting on this year's Super Bowl, a trend that's likely to continue for years to... 
Via Benzinga
Dominion Energy, Under Armour, And Expedia Among Another Slew Of Earnings Reports
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. (Friday Market Open) Equity index... 
Via Benzinga
Expert Ratings For Illumina
Over the past 3 months, 5 analysts have published their opinion on Illumina (NASDAQ:ILMN) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-... 
Via Benzinga
10 Biggest Price Target Changes For Friday
SVB Leerink cut Illumina, Inc. (NASDAQ: ILMN) price target from $430 to $400. Illumina shares fell 0.7% to $355.70 in pre-market trading. 
Via Benzinga
A Peek Into The Markets: US Stock Futures Down Following Thursday's Plunge
Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones tumbled more than 500 points in the previous session. Investors are awaiting earnings... 
Via Benzinga
5 Stocks To Watch For February 11, 2022
Some of the stocks that may grab investor focus today are: 
Via Benzinga
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.